Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.
Samur MK, Roncador M, Aktas Samur A, Fulciniti M, Bazarbachi AH, Szalat R, Shammas MA, Sperling AS, Richardson PG, Magrangeas F, Minvielle S, Perrot A, Corre J, Moreau P, Thakurta A, Parmigiani G, Anderson KC, Avet-Loiseau H, Munshi NC. Samur MK, et al. Among authors: anderson kc. Blood. 2023 Apr 6;141(14):1724-1736. doi: 10.1182/blood.2022017094. Blood. 2023. PMID: 36603186 Free PMC article.
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
Alyea E, Weller E, Schlossman R, Canning C, Webb I, Doss D, Mauch P, Marcus K, Fisher D, Freeman A, Parikh B, Gribben J, Soiffer R, Ritz J, Anderson K. Alyea E, et al. Blood. 2001 Aug 15;98(4):934-9. doi: 10.1182/blood.v98.4.934. Blood. 2001. PMID: 11493435 Free article. Clinical Trial.
Thalidomide: emerging role in cancer medicine.
Richardson P, Hideshima T, Anderson K. Richardson P, et al. Annu Rev Med. 2002;53:629-57. doi: 10.1146/annurev.med.53.082901.104043. Annu Rev Med. 2002. PMID: 11818493 Review.
Thalidomide in multiple myeloma.
Richardson P, Hideshima T, Anderson K. Richardson P, et al. Biomed Pharmacother. 2002 May;56(3):115-28. doi: 10.1016/s0753-3322(02)00168-3. Biomed Pharmacother. 2002. PMID: 12046682 Review.
Proteasome inhibition in hematologic malignancies.
Richardson PG, Hideshima T, Mitsiades C, Anderson K. Richardson PG, et al. Ann Med. 2004;36(4):304-14. doi: 10.1080/07853890410030877. Ann Med. 2004. PMID: 15224657 Review.
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.
Richardson P, Schlossman R, Jagannath S, Alsina M, Desikan R, Blood E, Weller E, Mitsiades C, Hideshima T, Davies F, Doss D, Freeman A, Bosch J, Patin J, Knight R, Zeldis J, Dalton W, Anderson K. Richardson P, et al. Mayo Clin Proc. 2004 Jul;79(7):875-82. doi: 10.4065/79.7.875. Mayo Clin Proc. 2004. PMID: 15244383 Clinical Trial.
1,201 results